Thermo Fisher's acquisition engine is still powerful, but Q1 2026 showed why the premium-multiple debate needs a harder evidence gate: 6% reported revenue growth, 1% organic growth, a major Clario acquisition, higher debt and a larger goodwill/intangible asset base.
Thermo Fisher: Can inorganic M&A growth sustain the premium earnings multiple today?
NYSETMOThermo FisherM&A
Thesis summary
Thermo Fisher's acquisition engine is still powerful, but Q1 2026 showed why the premium-multiple debate needs a harder evidence gate: 6% reported revenue growth, 1% organic growth, a major Clario acquisition, higher debt and a larger goodwill/intangible asset base.
View article
Discuss the thesis
0 commentsCommenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.
No comments yet. Start the discussion with evidence, a question, or a bear case.